Tìm kiếm
Charles River Laboratories International Inc
CRLThêm vào danh sách theo dõi
234.300USD
-0.500-0.21%
Đóng cửa 07-29 16:00（ET）Báo giá bị trễ 15 phút
11.29BVốn hóa
LỗP/E TTM
Thêm thông tin về Charles River Laboratories International Inc Công ty
Charles River Laboratories International, Inc. is a drug development company. It provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and academic institutions around the globe accelerate their research and drug development efforts. Its Research Models and Services segment includes three businesses that provide foundational tools that enable its clients to discover new molecules: Research Models, Research Model Services, and Cell Solutions. Its Discovery and Safety Assessment segment provides regulated and non-regulated DSA services to support the research, development, and regulatory-required safety testing of potential new drugs, including therapeutic discovery and optimization plus in vitro and in vivo studies, laboratory support services, and strategic non-clinical consulting and program management to support product development. Its Manufacturing Solutions segment includes Microbial Solutions and Biologics Solutions.
Thông tin của Charles River Laboratories International Inc
Mã chứng khoánCRL
Tên công tyCharles River Laboratories International Inc
Ngày IPOJun 23, 2000
Giám đốc điều hànhFoster (James C)
Số lượng nhân viên18600
Loại chứng khoánOrdinary Share
Kết thúc năm tài chínhJun 23
Địa chỉ251 Ballardvale St
Thành phốWILMINGTON
Sàn giao dịch chứng khoánNASDAQ OMX NASDAQ Basic NYSE
Quốc giaUnited States of America
Mã bưu điện01887
Điện thoại17812226000
Trang webhttps://www.criver.com/
Mã chứng khoánCRL
Ngày IPOJun 23, 2000
Giám đốc điều hànhFoster (James C)
Lãnh đạo công ty của Charles River Laboratories International Inc
Tên
Tên/Chức vụ
Chức vụ
Tỷ lệ sở hữu cổ phần
Thay đổi
Ms. Birgit Girshick
Ms. Birgit Girshick
Chief Operating Officer, Corporate Executive Vice President
Chief Operating Officer, Corporate Executive Vice President
58.79K
-5.76%
Mr. James C. Foster
Mr. James C. Foster
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
26.98K
-920.54%
Ms. Victoria L. (Vicky) Creamer
Ms. Victoria L. (Vicky) Creamer
Corporate Executive Vice President, Chief People Officer
Corporate Executive Vice President, Chief People Officer
20.94K
+19.00%
Mr. Joseph W. LaPlume
Mr. Joseph W. LaPlume
Corporate Executive Vice President - Corporate Development and Strategy
Corporate Executive Vice President - Corporate Development and Strategy
14.72K
+26.15%
Ms. Shannon M. Parisotto
Ms. Shannon M. Parisotto
Corporate Executive Vice President - Discovery and Safety Assessment
Management
Corporate Executive Vice President - Discovery and Safety Assessment
Management
10.72K
-14.26%
Ms. Virginia M. (Gina) Wilson, CPA
Ms. Virginia M. (Gina) Wilson, CPA
Independent Director
Independent Director
6.35K
+22.65%
Ms. Reshema Kemps-Polanco
Ms. Reshema Kemps-Polanco
Independent Director
Independent Director
4.56K
+43.24%
Dr. Craig B. Thompson, M.D.
Dr. Craig B. Thompson, M.D.
Independent Director
Independent Director
3.85K
+37.34%
Mr. Abraham N. (Abe) Ceesay
Mr. Abraham N. (Abe) Ceesay
Independent Director
Independent Director
2.38K
+60.32%
Mr. Paul W. Graves
Mr. Paul W. Graves
Independent Director
Independent Director
2.38K
+60.32%
Xem thêm
Tên
Tên/Chức vụ
Chức vụ
Tỷ lệ sở hữu cổ phần
Thay đổi
Ms. Birgit Girshick
Ms. Birgit Girshick
Chief Operating Officer, Corporate Executive Vice President
Chief Operating Officer, Corporate Executive Vice President
58.79K
-5.76%
Mr. James C. Foster
Mr. James C. Foster
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
26.98K
-920.54%
Ms. Victoria L. (Vicky) Creamer
Ms. Victoria L. (Vicky) Creamer
Corporate Executive Vice President, Chief People Officer
Corporate Executive Vice President, Chief People Officer
20.94K
+19.00%
Mr. Joseph W. LaPlume
Mr. Joseph W. LaPlume
Corporate Executive Vice President - Corporate Development and Strategy
Corporate Executive Vice President - Corporate Development and Strategy
14.72K
+26.15%
Ms. Shannon M. Parisotto
Ms. Shannon M. Parisotto
Corporate Executive Vice President - Discovery and Safety Assessment
Management
Corporate Executive Vice President - Discovery and Safety Assessment
Management
10.72K
-14.26%
Ms. Virginia M. (Gina) Wilson, CPA
Ms. Virginia M. (Gina) Wilson, CPA
Independent Director
Independent Director
6.35K
+22.65%
Câu hỏi thường gặp
Ai là năm cổ đông lớn nhất của Charles River Laboratories International Inc?
Năm cổ đông hàng đầu của Charles River Laboratories International Inc là: Ms. Birgit Girshick
Có bao nhiêu tổ chức nắm giữ cổ phiếu của Charles River Laboratories International Inc (CRL)?
Tính đến ngày 2026Q1, có 1429 tổ chức nắm giữ cổ phiếu của Charles River Laboratories International Inc, với tổng giá trị thị trường khoảng 56.13M, chiếm 116.51% tổng số cổ phiếu. So với ngày 2025Q4, tỷ lệ cổ phần của các tổ chức đã tăng thêm -7963916.00.
Nguồn doanh thu lớn nhất của Charles River Laboratories International Inc là gì?
Vào ngày 2026Q1, bộ phận kinh doanh DSA đã tạo ra doanh thu cao nhất cho Charles River Laboratories International Inc, đạt 2.40B, chiếm 59.84% tổng doanh thu.